Once per cycle pegfilgrastim versus daily filgrastim in pediatric patients with Ewing sarcoma.

被引：0
|
作者：
Wendelin, G [1 ]
Lackner, H [1 ]
Schwinger, W [1 ]
Sovinz, P [1 ]
Urban, C [1 ]
机构：
[1] Med Univ Graz, Dept Pediat Hematol & Oncol, Graz, Austria
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.2919.2919
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2919
引用
收藏
页码：798A / 798A
页数：1
相关论文
共 50 条
  • [1] Once-per-cycle pegfilgrastim versus daily filgrastim in pediatric patients with Ewing sarcoma
    Wendelin, G
    Lackner, H
    Schwinger, W
    Sovinz, P
    Urban, C
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2005, 27 (08) : 449 - 451
  • [2] Once per cycle pegfilgrastim compaired to daily filgrastim after myelosuppressive chemotherapy in paediatric cancer patients
    Cacchione, Antonella
    Ferrara, Eva
    Roberti, Micol
    D'Attilia, Francesca
    Schiavo, Elisa
    Cappelli, Carlo
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 512 - 512
  • [3] Benefits for pediatric patients in chemotherapy! A single dose of Pegfilgrastim versus daily Filgrastim
    Swinkels, I.
    Daemen, I.
    Maaskant, J.
    Unk, K.
    Smid, A.
    EUROPEAN JOURNAL OF PEDIATRICS, 2016, 175 (11) : 1625 - 1625
  • [4] A comparison of outcomes, presentation, and treatment in pediatric (Ped) versus adult patients (Pts) with Ewing sarcoma.
    Schwartz, Eric B.
    Zhao, Lili
    Siontis, Brittany
    Baker, Laurence H.
    Rao, Rama
    Lawlor, Elizabeth R.
    Schuetze, Scott
    Chugh, Rashmi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] An open-label, randomized, multicenter dose-finding study of once-per-cycle pegfilgrastim versus daily filgrastim in Chinese breast cancer patients receiving TAC chemotherapy
    Wei Zhang
    Zhiwei Jiang
    Ling Wang
    Chanjuan Li
    Jielai Xia
    Medical Oncology, 2015, 32
  • [6] An open-label, randomized, multicenter dose-finding study of once-per-cycle pegfilgrastim versus daily filgrastim in Chinese breast cancer patients receiving TAC chemotherapy
    Zhang, Wei
    Jiang, Zhiwei
    Wang, Ling
    Li, Chanjuan
    Xia, Jielai
    MEDICAL ONCOLOGY, 2015, 32 (05) : 1 - 7
  • [7] Analysis on cost difference between daily filgrastim and once per cycle pegfilgrastim for prophylaxis against chemotherapy-induced neutropenia in France and Germany
    Suzcs, TD
    Standaert, B
    Lu, ZJ
    VALUE IN HEALTH, 2003, 6 (06) : 732 - 732
  • [8] Prognostic value of tumor response in pediatric and adult patients with Ewing sarcoma.
    Chihak, Melanie Ann
    Keeney, Michael Gary
    Fritchie, Karen
    Harmsen, William S.
    Arndt, Carola A. S.
    Ruddy, Kathryn Jean
    Ahmed, Safia K.
    Laack, Nadia N.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [9] Cost-minimization analysis of once-per-cycle fixed-dose administration of pegfilgrastim versus daily filgrastim for the prophylaxis of chemotherapy-induced febrile neutropenia in Brazil
    Lago, S.
    Nasciben, V
    Saggia, M. G.
    VALUE IN HEALTH, 2007, 10 (06) : A332 - A332
  • [10] Single administration of pegylated filgrastim once per cycle compared to daily filgrastim in patients with primary breast cancer receiving neoadjuvant chemotherapy.
    Wenzel, C
    Bartsch, R
    Hussian, D
    Pluschnig, U
    Locker, GJ
    Sevelda, U
    Zielinski, CC
    Steger, GG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 780S - 780S
12345